Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | May 05, 2025 01:05pm

Gainers

  • NuCana (NASDAQ:NCNA) stock moved upwards by 52.8% to $0.7 during Monday's regular session. The company's market cap stands at $4.2 million.
  • Immutep (NASDAQ:IMMP) stock moved upwards by 35.6% to $2.32. The market value of their outstanding shares is at $337.2 million.
  • INVO Fertility (NASDAQ:IVF) stock moved upwards by 33.33% to $2.4. The company's market cap stands at $11.8 million.
  • Regencell Bioscience (NASDAQ:RGC) shares moved upwards by 31.91% to $80.8. The company's market cap stands at $1.0 billion.
  • Alterity Therapeutics (NASDAQ:ATHE) shares rose 23.54% to $4.25. The company's market cap stands at $62.9 million.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares increased by 23.2% to $0.31. The market value of their outstanding shares is at $4.3 million.

Losers

  • Integra Lifesciences (NASDAQ:IART) stock decreased by 26.4% to $12.4 during Monday's regular session. The company's market cap stands at $957.9 million. As per the news, the Q1 earnings report came out today.
  • Nexalin Technology (NASDAQ:NXL) shares decreased by 23.47% to $1.37. The market value of their outstanding shares is at $18.2 million.
  • Impact BioMedical (AMEX:IBO) shares declined by 22.46% to $0.58. The market value of their outstanding shares is at $6.6 million.
  • AirSculpt Technologies (NASDAQ:AIRS) stock fell 21.2% to $2.38. The market value of their outstanding shares is at $139.4 million. As per the press release, Q1 earnings came out yesterday.
  • ImmunityBio (NASDAQ:IBRX) stock declined by 19.49% to $2.04. The market value of their outstanding shares is at $1.8 billion.
  • PTC Therapeutics (NASDAQ:PTCT) stock declined by 17.48% to $41.22. The market value of their outstanding shares is at $3.2 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AIRS ATHE CYCC IART IBO IBRX IMMP IVF NCNA NXL PTCT RGC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist